Picture of Interpace Biosciences logo

IDXG Interpace Biosciences News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Brief: Interpace Biosciences Announces Path Forward In Letter To Shareholders

Feb 16 (Reuters) - Interpace Biosciences Inc  IDXG.O :
    * INTERPACE BIOSCIENCES ANNOUNCES PATH FORWARD IN LETTER TO
SHAREHOLDERS
    * COMPANY HAS NOW PUT IN PLACE A RESTRUCTURING AND
REPRIORITIZATION PLAN
    * COMPANY WILL SEEK TO ACHIEVE ANNUALIZED SAVINGS OF
APPROXIMATELY
$7.2 MILLION FROM ITS COST STRUCTURE
    * IN ANTICIPATION OF BEING DELISTED FROM NASDAQ, COMPANY HAS
APPLIED TO BE LISTED ON OTCQX
    * ANTICIPATE THIS WILL HELP COMPANY REALIZE $4.5-$4.9
MILLION IN
COST SAVINGS BY END OF 2021, NET OF INVESTMENTS

Source text for Eikon:  ID:nGNX9F3VCx 
Further company coverage:  IDXG.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Interpace Biosciences

See all news